Realgar-Indigo Naturalis Formulation

DRUG2 trials

Sponsors

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Instituto do Cancer do Estado de São Paulo

Conditions

Acute Promyelocytic Leukemia (APL)Rhabdomyosarcoma, Child

Phase 2

Radiotherapy Combined With Realgar-Indigo Naturalis Formula (RIF) in the Treatment of Rhabdomyosarcoma(RMS) in Children

Xinhua Hospital, Shanghai Jiao Tong University School of MedicineRhabdomyosarcoma, Child

Start: 2023-01-31End: 2024-12-30Target: 53Updated: 2023-02-01

Oral Arsenic With ATRA for Newly Diagnosed Patients With Acute Promyelocytic Leukemia

RecruitingNCT06982274

Instituto do Cancer do Estado de São PauloAcute Promyelocytic Leukemia (APL)

Start: 2023-10-20End: 2029-11-30Target: 115Updated: 2025-05-30